N-(4-Methyl-3-((1-(quinoline-3-carbonyl)piperidin-4-yl)oxy)-phenyl)-4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)benzamide

ID: ALA3931380

Chembl Id: CHEMBL3931380

PubChem CID: 134138260

Max Phase: Preclinical

Molecular Formula: C36H38F3N5O3

Molecular Weight: 645.73

Molecule Type: Small molecule

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1OC1CCN(C(=O)c2cnc3ccccc3c2)CC1

Standard InChI:  InChI=1S/C36H38F3N5O3/c1-24-7-10-29(41-34(45)26-8-9-27(31(20-26)36(37,38)39)23-43-17-15-42(2)16-18-43)21-33(24)47-30-11-13-44(14-12-30)35(46)28-19-25-5-3-4-6-32(25)40-22-28/h3-10,19-22,30H,11-18,23H2,1-2H3,(H,41,45)

Standard InChI Key:  SPIRYEARWAKBCH-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA3931380

    ---

Associated Targets(Human)

KIT Tclin Stem cell growth factor receptor (10667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BCR/ABL BCR/ABL p210 fusion protein (42 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 645.73Molecular Weight (Monoisotopic): 645.2927AlogP: 6.25#Rotatable Bonds: 7
Polar Surface Area: 78.01Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 7.57CX LogP: 5.35CX LogD: 4.96
Aromatic Rings: 4Heavy Atoms: 47QED Weighted: 0.26Np Likeness Score: -1.54

References

1. Wang Q, Liu F, Wang B, Zou F, Qi Z, Chen C, Yu K, Hu C, Qi S, Wang W, Hu Z, Liu J, Wang W, Wang L, Liang Q, Zhang S, Ren T, Liu Q, Liu J..  (2017)  Discovery of 4-Methyl-N-(4-((4-methylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)-3-((1-nicotinoylpiperidin-4-yl)oxy)benzamide (CHMFL-ABL/KIT-155) as a Novel Highly Potent Type II ABL/KIT Dual Kinase Inhibitor with a Distinct Hinge Binding.,  60  (1): [PMID:27966954] [10.1021/acs.jmedchem.6b01290]

Source